Skip to search formSkip to main contentSkip to account menu

SUMO4 gene

Known as: SMALL UBIQUITIN-LIKE MODIFIER 4, SUMO4, dJ281H8.4 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
SUMO4 163 G>A variation is associated with kidney disease in Indian subjects with type 2 diabetes
Genetic susceptibility probably plays a role in the development and/or progression of diabetic kidney disease. Small ubiquitin… 
2012
2012
Association between the SUMO4 M55V (A163G) polymorphism and susceptibility to type 1 diabetes: a meta-analysis.
Review
2012
Review
2012
The genetics of Behçet’s disease in a Chinese population
Behçet’s disease is defined as a multisystemic inflammatory disease. Although the precise pathogenesis and etiology is still a… 
2010
2010
No association of the SUMO4 polymorphism M55V variant in type 2 diabetes in Iranian subjects.
2010
2010
Association between small ubiquitin-like modifer 4 M55V polymorphism with type 2 diabetes and related factors
Objective To investigate the relationship between small ubiquitin-like modifer 4 M55V polymorphism with type 2 diabetes and… 
Review
2010
Review
2010
Association of SUMO4 M55V polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta‐analysis
The purpose of this study was to generate large‐scale evidence on whether SUMO4 M55V polymorphism is associated with autoimmune… 
2007
2007
Affinity chromatography of native SUMO proteins using His-tagged recombinant UBC9 bound to Co2+-charged talon resin.
2007
2007
A M55V Polymorphism in the SUMO4 Gene is Associated with a Reduced Prevalence of Diabetic Retinopathy in Patients with Type 1 Diabetes
Aims: Methods: Results: Conclusions: 
2006
2006
SLC22A4, RUNX1, and SUMO4 polymorphisms are not associated with rheumatoid arthritis: a case-control study in a Spanish population.
OBJECTIVE To replicate the association reported in Japanese individuals of functional SLC22A4 and RUNX1 polymorphisms with… 
2005
2005
Functional variants in SUMO4, TAB2, and NFκB and the risk of type 1 diabetes
Several functional genetic variants that can potentially modulate the activity of NFκB have been recently described. As reduced… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)